JP2025535192A5 - - Google Patents

Info

Publication number
JP2025535192A5
JP2025535192A5 JP2025542435A JP2025542435A JP2025535192A5 JP 2025535192 A5 JP2025535192 A5 JP 2025535192A5 JP 2025542435 A JP2025542435 A JP 2025542435A JP 2025542435 A JP2025542435 A JP 2025542435A JP 2025535192 A5 JP2025535192 A5 JP 2025535192A5
Authority
JP
Japan
Prior art keywords
human
antigen
lilrb1
lilrb2
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025542435A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025535192A (ja
Filing date
Publication date
Priority claimed from GBGB2214614.6A external-priority patent/GB202214614D0/en
Application filed filed Critical
Priority claimed from PCT/GB2023/050592 external-priority patent/WO2023170434A1/en
Publication of JP2025535192A publication Critical patent/JP2025535192A/ja
Publication of JP2025535192A5 publication Critical patent/JP2025535192A5/ja
Pending legal-status Critical Current

Links

JP2025542435A 2022-10-04 2023-03-13 マクロファージ活性の調整のための組成物及び方法 Pending JP2025535192A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2214614.6A GB202214614D0 (en) 2022-10-04 2022-10-04 Compositions and methods for modulation of macrophage
GB2214614.6 2022-10-04
PCT/GB2023/050592 WO2023170434A1 (en) 2022-03-11 2023-03-13 Compositions and methods for modulation of macrophage activity

Publications (2)

Publication Number Publication Date
JP2025535192A JP2025535192A (ja) 2025-10-22
JP2025535192A5 true JP2025535192A5 (cg-RX-API-DMAC7.html) 2026-03-24

Family

ID=84000149

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025542435A Pending JP2025535192A (ja) 2022-10-04 2023-03-13 マクロファージ活性の調整のための組成物及び方法

Country Status (8)

Country Link
JP (1) JP2025535192A (cg-RX-API-DMAC7.html)
KR (1) KR20250096720A (cg-RX-API-DMAC7.html)
CN (1) CN120435496A (cg-RX-API-DMAC7.html)
AU (1) AU2023232991A1 (cg-RX-API-DMAC7.html)
CR (1) CR20250172A (cg-RX-API-DMAC7.html)
GB (1) GB202214614D0 (cg-RX-API-DMAC7.html)
IL (1) IL319958A (cg-RX-API-DMAC7.html)
MX (1) MX2025003929A (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
CN103260646B (zh) Notum蛋白调节剂和使用方法
JP7209464B2 (ja) ヒトインターロイキン－２に対する免疫刺激性モノクローナル抗体
CN112969476B (zh) 多特异性蛋白分子
JP2020534830A5 (cg-RX-API-DMAC7.html)
JP2022509930A (ja) 抗ｃｄ７３抗体、その抗原結合フラグメントおよびそれらの使用
CN108084265B (zh) 特异性结合人的5t4抗原的全人源单域抗体及其应用
JP2021511811A5 (cg-RX-API-DMAC7.html)
JP2017538439A5 (cg-RX-API-DMAC7.html)
JP2013544493A5 (cg-RX-API-DMAC7.html)
JP2020501598A5 (cg-RX-API-DMAC7.html)
CN105209493A (zh) 用于诊断和治疗用途的her3特异性单克隆抗体
IL273196B1 (en) Claudin 6 antibodies and methods of cancer treatment
JP2016526904A5 (cg-RX-API-DMAC7.html)
JP2023527937A5 (cg-RX-API-DMAC7.html)
CN112574308A (zh) 靶向bcma的抗体、双特异性抗体及其用途
JP2017521054A5 (cg-RX-API-DMAC7.html)
JP2021516051A5 (cg-RX-API-DMAC7.html)
CN108164600B (zh) 一种抗gpc3抗体及其制备方法和用途
CN112940124A (zh) 靶向Claudin18.2的人源化单克隆抗体及其制备方法和应用
WO2014068300A1 (en) Anti-s100a4 antibody molecules and their uses
JP2020037571A (ja) Ｔｍｃｃ３の阻害による、癌を抑制するための方法
CN106749667A (zh) 一种抗癌胚抗原的纳米抗体及其应用
JP2025514636A5 (cg-RX-API-DMAC7.html)
JP2018528759A5 (cg-RX-API-DMAC7.html)
WO2023071676A1 (zh) 一种抗her2/抗pd-l1双功能抗体及其应用